EDGE MEDICAL-B (02675) has announced its intention to explore the preliminary proposal of issuing RMB-denominated shares, initiating plans for an initial public offering of ordinary RMB shares and listing on the A-share market (the proposed A-share listing).

The proposed issuance of RMB shares is subject to and contingent upon, among other things, market conditions, further approval from the board of directors, approval from the company's shareholders at a general meeting, and approvals from relevant regulatory authorities.

In connection with the proposed A-share listing, the company has engaged a pre-listing counselling institution and submitted a registration application for pre-IPO counselling on September 11, 2026. As of the date of this announcement, apart from the information disclosed herein, the board has not approved any other plans regarding the proposed A-share listing, nor has it filed any applications with relevant regulatory authorities in China or any other jurisdiction in connection with the proposed A-share listing.